Peripheral Arterial Disease Therapeutics Pipeline Analysis, 2017 - Patent, Designation, Collaboration, and Other Developments

On account of increasing number of cases related to high blood pressure and diabetes, growth in pipeline of peripheral arterial disease is anticipated in the next few years. One of the main causes of peripheral arterial disease is smoking, which leads to the building up of plaque inside the arteries that carry oxygen rich blood. As per the data provided by World Health Organization in 2015, nearly 1.1 billion people were addicted to smoking. Moreover, increasing number of people are being diagnosed with high blood pressure, diabetes and other lifestyle related diseases on account of unhealthy dietary habits, growing pressure at work, etc. On the back of these factors, growth in pipeline of peripheral arterial disease therapeutics is anticipated over next few years.

Explore Report at: www.psmarketresearch.com/market-analysis/peripheral-arterial-disease-therapeutics-pipeline-analysis

According to the National Institute of Heart, Lung and Blood Institute, peripheral arterial disease is caused by formation of plaque in arteries, which can translocate to other organs such as head and limbs. Fat, cholesterol, calcium and other fibrous tissues are responsible for the formation of plaque, in turn resulting in, Atherosclerosis, a condition that transpires in plaque build-up. It also leads to hardening and narrowing of the arteries, which limits the supply of oxygen-rich blood to the body. It generally occurs in legs, but it can also occur in arteries that carry blood to the head, arms, kidney and stomach. Sometimes, blockage in blood flow can cause numbness and pain in that area of the body, in turn amplifying the chances of infection to the affected limbs and, in severe cases, it can cause gangrene.

Request for table of Content at: www.psmarketresearch.com/market-analysis/peripheral-arterial-disease-therapeutics-pipeline-analysis/toc-sample

Some of the companies having a pipeline of peripheral arterial disease therapeutics include Bayer AG, Juventas Therapeutics, Inc., Proteon Therapeutics, Inc., Humacyte, Inc., Veryan Medical Ltd., SurModics, Inc., Acotec Scientific Co., Ltd, Spectranetics Corporation, Cardionovum GmbH.

Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Kundan
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

347, 5th Ave. #1402
New York City, NY - 10016

This release was published on openPR.